Mississauga
Canada
91
2026-04-30
The entities that hold a legal rights for patent applications filed by inventor Slassi Abdelmalik:
Abdelmalik Slassi from Mississauga, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#2 | 2026-03-26INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#3 | 2025-12-25PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#4 | 2025-11-20INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#5 | 2025-01-303-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#6 | 2024-12-26CONJUGATES COMPRISING ANTIFUNGALS AND HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS AND METHODS OF USE THEREOF
#7 | 2024-11-21INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#8 | 2024-11-14N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#9 | 2024-10-17HALLUCINOGEN-FATTY ACID COMBINATION
#10 | 2024-10-103-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#11 | 2024-09-26PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#12 | 2024-05-23INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#13 | 2024-05-23INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#14 | 2024-02-153-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#15 | 2023-09-14SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN
#16 | 2023-06-29PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#17 | 2023-06-01PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#18 | 2023-04-20Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#19 | 2023-04-063-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#20 | 2022-10-13Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#21 | 2022-09-15Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#22 | 2022-01-27PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#23 | 2022-01-203-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#24 | 2022-01-20Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
#25 | 2020-06-11FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
#26 | 2020-01-30HETEROAROMATIC-FUSED IMIDAZOLYL AMIDES, COMPOSITIONS AND USES THEREOF AS STING AGONISTS
#27 | 2019-12-05HETEROCYCLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS
#28 | 2019-07-04Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
#29 | 2019-01-17NOVEL FLUORINATED QUINAZOLINE DERIVATIVES AS EGFR INHIBITORS
#30 | 2018-11-22Fluorinated amide derivatives and their uses as therapeutic agents
#31 | 2018-11-01Heterocycle derivatives and their use for the treatment of CNS disorders
#32 | 2018-02-22NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERS
#33 | 2018-01-18Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
#34 | 2018-01-18PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDS
#35 | 2016-12-01FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS
#36 | 2015-08-06FLUORINATED EPOXYKETONE-BASED TETRAPEPTIDE COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS
#37 | 2015-07-23Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors
#38 | 2014-01-16USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS
#39 | 2012-11-29AZAINDOLES HAVING SEROTONIN RECEPTOR AFFINITY
#40 | 2012-03-15Treatment of muscle disease characterized by insulin resistance
#41 | 2011-07-07Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators
#42 | 2011-03-03AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
#43 | 2010-12-16Metabotropic glutamate-receptor-potentiating isoindolones
#44 | 2010-11-04Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators
#45 | 2010-01-21Use of D-serine derivatives for the treatment of anxiety disorders
#46 | 2009-07-30Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
#47 | 2009-06-11Metabotropic Glutamate Receptor-Potentiating Isoindolones
#48 | 2009-05-14Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
#49 | 2009-04-30Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
#50 | 2009-03-12Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders
#51 | 2009-02-26Use
#52 | 2009-01-22Piperazines and piperidines as Mglur5 potentiators
#53 | 2009-01-08Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
#54 | 2008-12-25Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators
#55 | 2008-12-18Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists
#56 | 2008-12-18Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
#57 | 2008-12-11Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
#58 | 2008-12-11Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
#59 | 2008-09-185-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders
#60 | 2008-09-18Metabotropic glutamate-receptor-potentiating isoindolones
#61 | 2008-08-14Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists
#62 | 2008-05-29mGluR5 modulators
#63 | 2008-05-29Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
#64 | 2008-02-21ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
#65 | 2008-01-17ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
#66 | 2008-01-03Azaindoles having serotonin receptor affinity
#67 | 2007-12-20ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
#68 | 2007-11-22NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
#69 | 2007-11-22NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
#70 | 2007-11-08mGluR5 modulators III
#71 | 2007-11-08MGluR5 modulators IV
#72 | 2007-11-08mGluR5 modulators II
#73 | 2007-11-08MGluR5 modulators VI
#74 | 2007-11-08MGluR5 modulators I
#75 | 2007-11-08MGluR5 modulators V
#76 | 2007-08-09Triazole compounds and their use as metabotropic glutamate receptor antagonists
#77 | 2007-08-09Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
#78 | 2007-08-02Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
#79 | 2007-02-15Substituted piperazines as metabotropic glutamate receptor antagonists
#80 | 2007-02-15Bicyclic piperazines as metabotropic glutatmate receptor antagonists
#81 | 2006-10-19Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
#82 | 2006-07-11Compounds
#83 | 2006-06-08Compounds
#84 | 2006-03-23New compounds
#85 | 2006-02-02Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
#86 | 2006-01-26Triazole compounds and their use as metabotropic glutamate receptor antagonists
#87 | 2006-01-12Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
#88 | 2006-01-05Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
#89 | 2005-12-08Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
#90 | 2005-10-27Azaindoles having serotonin receptor affinity
#91 | 2005-07-12Azaindoles having serotonin receptor affinity
615639 ⎘